BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2020
View Archived Issues
MMA induces epithelial-to-mesenchymal transition
Read More
CAR T cells for inhibition
Read More
First healthy volunteers enrolled in phase I study of GRAd-COV2 COVID-19 vaccine candidate
Read More
Trevena initiates proof-of-concept study of TRV-027 in patients with COVID-19
Read More
BIIB-091: a potent, highly selective BTK inhibitor for the treatment of multiple sclerosis
Read More
GB-1211, first orally available galectin-3 inhibitor as potential treatment for NASH
Read More
Nicotinamide riboside suppresses inflammatory activation of PBMC in heart failure
Read More
Kyorin Pharmaceutical presents new 15-PGDH inhibitors
Read More
New DNA polymerase theta inhibitors discovered at Ideaya Biosciences
Read More
Foghorn Therapeutics patents PROTACs targeting BRD9
Read More
Canwell Biotech identifies new TLR7/8 agonists
Read More
New sphingomyelin phosphodiesterase 3 inhibitors discovered at Johns Hopkins University
Read More
Antifungal immunity helps out antibacterial vaccine
Read More
FDA clears IND for phase II study of RGX-314 for diabetic retinopathy
Read More
Immunogenicity of an saRNA lipid NP vaccine candidate encoding the SARS-CoV-2 S protein in mice
Read More
Topline data presented from phase II ELEKTRA study of soticlestat
Read More
AtlasMedx initiates phase I/II study of AMXI-5001 in advanced malignancies
Read More
Positive topline data from phase IIa trial of IMVT-1401 in myasthenia gravis
Read More
Mereo BioPharma initiates phase Ib/II study of alvelestat in COVID-19 respiratory disease
Read More
Phase III ASCEMBL study of asciminib in CML meets primary endpoint
Read More
